These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24122937)

  • 1. Dried blood spots for HIV-1 drug resistance genotyping in decentralized settings in Senegal.
    Diouara AA; Diop-Ndiaye H; Kebe-Fall K; Tchiakpè E; Ndiaye O; Ayouba A; Peeters M; Mboup S; Kane CT
    J Med Virol; 2014 Jan; 86(1):45-51. PubMed ID: 24122937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral treatment outcome in HIV-1-infected patients routinely followed up in capital cities and remote areas of Senegal, Mali and Guinea-Conakry.
    Diouara AA; Ndiaye HD; Guindo I; Bangoura N; Cissé M; Edmond T; Bougoudogo F; Mboup S; Peeters M; Ayouba A; Kane NC
    J Int AIDS Soc; 2014; 17(1):19315. PubMed ID: 25527333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy.
    Rottinghaus EK; Ugbena R; Diallo K; Bassey O; Azeez A; Devos J; Zhang G; Aberle-Grasse J; Nkengasong J; Yang C
    Clin Infect Dis; 2012 Apr; 54(8):1187-95. PubMed ID: 22412066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.
    Monleau M; Aghokeng AF; Eymard-Duvernay S; Dagnra A; Kania D; Ngo-Giang-Huong N; Touré-Kane C; Truong LX; Chaix ML; Delaporte E; Ayouba A; Peeters M;
    J Clin Microbiol; 2014 Feb; 52(2):578-86. PubMed ID: 24478491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal.
    Kane CT; Ndiaye HD; Diallo S; Ndiaye I; Wade AS; Diaw PA; Gaye-Diallo A; Mboup S
    J Virol Methods; 2008 Mar; 148(1-2):291-5. PubMed ID: 18242718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance mutations and genetic diversity in adults treated for HIV type 1 infection in Mauritania.
    Fall-Malick FZ; Tchiakpé E; Ould Soufiane S; Diop-Ndiaye H; Mouhamedoune Baye A; Ould Horma Babana A; Touré Kane C; Lo B; Mboup S
    J Med Virol; 2014 Mar; 86(3):404-10. PubMed ID: 24318486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping.
    Monleau M; Butel C; Delaporte E; Boillot F; Peeters M
    J Antimicrob Chemother; 2010 Aug; 65(8):1562-6. PubMed ID: 20542904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.
    Kantor R; DeLong A; Balamane M; Schreier L; Lloyd RM; Injera W; Kamle L; Mambo F; Muyonga S; Katzenstein D; Hogan J; Buziba N; Diero L
    J Int AIDS Soc; 2014; 17(1):19262. PubMed ID: 25413893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings.
    Johannessen A; Trøseid M; Calmy A
    J Antimicrob Chemother; 2009 Dec; 64(6):1126-9. PubMed ID: 19776036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.
    Bronze M; Aitken SC; Wallis CL; Steegen K; Stuyver LJ; de Wit TF; Stevens W
    J Virol Methods; 2013 Dec; 194(1-2):300-7. PubMed ID: 23994150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High efficacy of first-line ART in a West African cohort, assessed by dried blood spot virological and pharmacological measurements.
    de Truchis P; Lê MP; Daou M; Madougou B; Nouhou Y; Moussa Saley S; Sani A; Adehossi E; Rouveix E; Saidou M; Peytavin G; Delaugerre C
    J Antimicrob Chemother; 2016 Nov; 71(11):3222-3227. PubMed ID: 27439522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
    Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
    J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of dried blood spot specimens for HIV-1 drug resistance genotyping in young children initiating antiretroviral therapy.
    Salimo AT; Ledwaba J; Coovadia A; Abrams EJ; Technau KG; Kuhn L; Morris L; Hunt GM
    J Virol Methods; 2015 Oct; 223():30-2. PubMed ID: 26192603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous Detection of Major Drug Resistance Mutations of HIV-1 Subtype B Viruses from Dried Blood Spot Specimens by Multiplex Allele-Specific Assay.
    Zhang G; Cai F; de Rivera IL; Zhou Z; Zhang J; Nkengasong J; Gao F; Yang C
    J Clin Microbiol; 2016 Jan; 54(1):220-2. PubMed ID: 26560533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay.
    Hallack R; Doherty LE; Wethers JA; Parker MM
    J Clin Virol; 2008 Apr; 41(4):283-7. PubMed ID: 18243787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field study of dried blood spot specimens for HIV-1 drug resistance genotyping.
    Parry CM; Parkin N; Diallo K; Mwebaza S; Batamwita R; DeVos J; Bbosa N; Lyagoba F; Magambo B; Jordan MR; Downing R; Zhang G; Kaleebu P; Yang C; Bertagnolio S
    J Clin Microbiol; 2014 Aug; 52(8):2868-75. PubMed ID: 24871219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.
    Cabrera C; Cozzi-Lepri A; Phillips AN; Loveday C; Kirk O; Ait-Khaled M; Reiss P; Kjaer J; Ledergerber B; Lundgren JD; Clotet B; Ruiz L;
    Antivir Ther; 2004 Oct; 9(5):787-800. PubMed ID: 15535417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania.
    Johannessen A; Garrido C; Zahonero N; Sandvik L; Naman E; Kivuyo SL; Kasubi MJ; Gundersen SG; Bruun JN; de Mendoza C
    Clin Infect Dis; 2009 Sep; 49(6):976-81. PubMed ID: 19663598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 degrees C.
    Youngpairoj AS; Masciotra S; Garrido C; Zahonero N; de Mendoza C; García-Lerma JG
    J Antimicrob Chemother; 2008 Jun; 61(6):1217-20. PubMed ID: 18344550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.